News – Page 726 – Endpoints News

BARDA bets $86M on ContraFect's PhIII bid against drug-resistant Staph

5 years ago

EMA begins safety review of bluebird gene therapy following AML case in related therapy

5 years ago

Covid-19 roundup: AstraZeneca cuts Q1 vaccine supply to EU by a third — report; Sanofi, Translate usher another ...

5 years ago

Monte Rosa pulls in $95M to test its 'molecular glues,' and the first target is GSPT1

5 years ago

Novavax final results show 96% efficacy in UK trial but plunge to about 50% in South African variant

5 years ago

Trump’s HHS planted ‘ticking timebomb’ to sunset thousands of regs, lawsuit says

5 years ago

Ani Pharma picks up generic player for a cool $210M, turbocharging its manufacturing and R&D wings

5 years ago

Covid-19 manufacturing roundup: Biden doubles down on vaccination plan with 100M-dose order; BioNTech, Pfizer ready ...

5 years ago

Prometheus upsizes IPO by 33% ahead of pricing; Humanigen secures loan of up to $80M to develop lenzilumab

5 years ago

Gilead partner touts an early snapshot of its HIV vaccine approach to a cure — but there's a long path ahead

5 years ago

Three-day FDA adcomm to feature unprecedented review of Merck, Roche and BMS accelerated approvals

5 years ago

Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker pivoted around Covid-19 vaccine R&D

5 years ago

Recall report: BRP Pharma pulls 47 bottles of generic diuretic spironolactone after mixing different strength pills

5 years ago

FDA delays Kadmon’s priority review as apparent clampdown continues

5 years ago

In race for in vivo sickle cell cure, Intellia unveils (very) early proof-of-concept

5 years ago

Covid-19 roundup: Pfizer/BioNTech release real-world evidence of vaccine efficacy; EMA gives J&J shot thumbs up

5 years ago

GlaxoSmithKline, Vir gear up for EUA, citing early PhIII Covid-19 win with 'best-in-class' antibody contender

5 years ago

In the latest twist to IL-6 roller coaster, Roche's Actemra fails PhIII Covid-19 Veklury combo trial

5 years ago

Aveo Oncology gets the long-awaited greenlight to market tivozanib — 9 years after filing its first NDA

5 years ago

Synthetic DNA player Touchlight scores $60M round to more than triple manufacturing capacity as mRNA gets hot

5 years ago

Janet Woodcock and Francis Collins dish on lessons learned from the pandemic

5 years ago

Arctic Vision collects $100M to bring US eye disease candidates overseas

5 years ago

Grifols snags the rest of GigaGen in $80M acquisition; Vertex moves cutting-edge diabetes treatment into the clinic

5 years ago

Bluebird execs exhale after ruling sickle cell therapy 'very unlikely' to have caused AML event. How will FDA react?

5 years ago

First page Previous page 723 724 725726727 728 729 Next page Last page